Merck Group appoints head of global procurement

Friedheim Felten takes up role on 1 April

Friedhelm Felten is to become head of corporate procurement, taking over responsibility for the global purchasing activities of the Merck Group.

Taking up the role on 1 April, Felten succeeds Friedrich Schmitt, who has headed the function since 1997 and will be retiring at the end of July. Felten will report to Michael Becker, chief financial officer.

Corporate procurement is responsible for purchasing production materials such as pharmaceutical raw materials and chemicals, and for procuring technical components such as production and laboratory equipment as well as services such as pharmaceutical research and development. The 500 members of the global matrix organisation handle an annual purchasing volume of around b4.5bn.

Felten joined Merck in July 2009 as head of procurement for Services. He has many years of management experience in purchasing and in other functions at international companies, including DHL Global Forwarding in Singapore, DHL Logistics in London, and BASF AG in Ludwigshafen, as well as various BASF subsidiaries in Asia.

You may also like

Research & Development
Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Cambridge-based biotech Mission Therapeutics has divested its Phase II-ready USP30 inhibitor MTX652 to renal specialist Dimerix in a deal worth up to $292m, allowing the company to accelerate its Parkinson’s disease pipeline
Manufacturing
Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
Finance
Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

The deal adds StatLab's 50-year histology workflow portfolio to Leica Biosystems' computational pathology platform, supporting laboratory standardisation for AI-driven cancer diagnostics at scale
Finance
Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

The private equity firm has agreed to acquire Germany's Primed Group, backing investment in medical consumables manufacturing, sterilisation services and international growth
Distribution
Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Agreement strengthens Brenntag’s position in biopharma and API markets in Europe
Manufacturing
Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

The deal pairs Nottingham's OSD development and clinical supply expertise with Codis' commercial-scale Haverhill facility, offering pharma partners an integrated ASD development-to-manufacture pathway within a single quality system
Finance
Novartis to acquire ADC biotech Myricx Bio for $1.5bn

Novartis to acquire ADC biotech Myricx Bio for $1.5bn

The pharma giant will add the biotech's novel NMTi payload platform to its roster, which may have potential in multiple solid tumour settings and overcome issues that have troubled ADC therapies, such as payload resistance and tolerability
Subscribe now